Genetic Technologies Rating Lowered to Neutral at Ladenburg Thalmann (GENE)
Genetic Technologies (NASDAQ:GENE) was downgraded by stock analysts at Ladenburg Thalmann from a “buy” rating to a “neutral” rating in a report issued on Friday, TheFlyOnTheWall.com reports.
Genetic Technologies (NASDAQ:GENE) opened at 0.72 on Friday. Genetic Technologies has a 1-year low of $0.66 and a 1-year high of $3.00. The stock’s 50-day moving average is $0.9 and its 200-day moving average is $1.25. The company’s market cap is $14.0 million.
Genetic Technologies Limited is engaged in a diagnostic product business. The Company translates genetic tests into products and services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.